EU Drug Regulatory Agency found connection between AstraZeneca vaccine and blood clots. Scientists claim - the benefits more than the risk of this vaccine. The agency is in favour of AstraZeneca's vaccine, the bid-risk is very low.
Today, the European Medical Agency (EMA) has made a big deal in the face of doubts in European countries about the Corona vaccine of London AstraZeneca. The European drug regulator has reported that it has found a possible link between AstraZeneca's coronavirus vaccine and the problem of rare blood clots. Still, the report also claimed that the benefits of this vaccine still outweigh the risks.
The European Medicines Agency, in a statement released on Wednesday, did not announce any new prohibitions on the use of the vaccine for people 18 years and older. Earlier this week, a senior agency official said a causal link was found between AstraZeneca vaccines and rare blood clots in dozens of thousands of people worldwide.
On Tuesday, Marco Cavalieri, head of the health-risk and vaccine strategy of the Amsterdam-based agency, told that it is becoming very difficult to say that AstraZeneca's vaccines and platelet depletion are associated with blood. There is no causal contact between extremely rare clots. The agency stated that its assessment has not yet reached a conclusion and is currently under review.
A few days ago, the EU drug regulator had reported that 30 cases of blood clotting have been identified by AstraZeneca's Coronavirus vaccine. Still, even then the agency urged that the benefits of this vaccine were more than any threat. The Drug and Health Care Regulatory Agency said that the risk connected with blood clotting in this way is very low and people should carry on with getting the vaccine.
In Europe, some people who were vaccinated with the Oxford / AstraZeneca had reported cases of blood clots, after which worries were expressed. Some countries, such as Germany, had asked people of specific age groups not to get this vaccine administered. simultaneously, both the European Drug Monitoring Organization and the World Health Organization have said that the vaccine is safe and useful.
The Brief. Sign up to receive the top stories you need to know right now.